GEMPHIRE THERAPEUTICS INC's ticker is GEMP and the CUSIP is 36870A108. A total of 26 filers reported holding GEMPHIRE THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $168,000 | +10.5% | 443,923 | +136.6% | 0.00% | – |
Q2 2019 | $152,000 | -20.4% | 187,588 | +13.4% | 0.00% | – |
Q1 2019 | $191,000 | +50.4% | 165,492 | +1.3% | 0.00% | – |
Q4 2018 | $127,000 | -83.9% | 163,292 | -57.3% | 0.00% | – |
Q3 2018 | $787,000 | -79.7% | 382,105 | +0.3% | 0.00% | – |
Q2 2018 | $3,883,000 | +58.1% | 381,091 | +1.0% | 0.00% | – |
Q1 2018 | $2,456,000 | +89.1% | 377,331 | +130.9% | 0.00% | – |
Q4 2017 | $1,299,000 | -11.3% | 163,434 | +5.3% | 0.00% | – |
Q3 2017 | $1,464,000 | +266.9% | 155,177 | +402.2% | 0.00% | – |
Q2 2017 | $399,000 | +193.4% | 30,898 | +137.6% | 0.00% | – |
Q1 2017 | $136,000 | – | 13,006 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|